Page last updated: 2024-08-24

adenosine and Abnormal Movements

adenosine has been researched along with Abnormal Movements in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Airas, L; Helin, S; Joutsa, J; Parkkola, R; Rinne, JO; Rissanen, E; Tuisku, J; Waggan, I	1
Müller, T	1
Nomoto, M	1
Agnati, LF; Ferré, S; Franco, R; Fuxe, K; Hockemeyer, J; Leo, G; Lluis, C; Martínez, E; Vergoni, AV	1
Aguilar, E; Bové, J; Cortés, R; Marin, C; Mengod, G; Serrats, J	1

Reviews

2 review(s) available for adenosine and Abnormal Movements

Article	Year
Suitability of the adenosine antagonist istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:8 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Blood-Brain Barrier; Disease Models, Animal; Dopamine Agonists; Dyskinesias; Half-Life; Humans; Levodopa; Parkinson Disease; Purines; Treatment Outcome	2013
[Pharmacological aspect of the mechanism and the treatment of involuntary movements]. Rinsho shinkeigaku = Clinical neurology, 2001, Volume: 41, Issue:12 Topics: Acetylcholine; Adenosine; Animals; Dopamine; Dyskinesias; Glutamates; Humans; Serotonin	2001

Article

Year

Suitability of the adenosine antagonist istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations.

Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:8

Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Blood-Brain Barrier; Disease Models, Animal; Dopamine Agonists; Dyskinesias; Half-Life; Humans; Levodopa; Parkinson Disease; Purines; Treatment Outcome

2013

[Pharmacological aspect of the mechanism and the treatment of involuntary movements].

Rinsho shinkeigaku = Clinical neurology, 2001, Volume: 41, Issue:12

Topics: Acetylcholine; Adenosine; Animals; Dopamine; Dyskinesias; Glutamates; Humans; Serotonin

2001

Other Studies

3 other study(ies) available for adenosine and Abnormal Movements

Article	Year
Adenosine A Journal of neurology, 2023, Volume: 270, Issue:1 Topics: Adenosine; Dyskinesias; Humans; Levodopa; Parkinson Disease; Receptor, Adenosine A2A	2023
Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease. Brain research bulletin, 2004, Aug-30, Volume: 64, Issue:2 Topics: Adenosine; Adenosine A2 Receptor Agonists; Analysis of Variance; Animals; Antiparkinson Agents; Apomorphine; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Drug Therapy, Combination; Dyskinesias; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinson Disease; Phenethylamines; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Sympatholytics; Time Factors; Tyrosine 3-Monooxygenase	2004
Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats. Synapse (New York, N.Y.), 2006, Jun-01, Volume: 59, Issue:7 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine; Adrenergic Agents; Animals; Caffeine; Corpus Striatum; Dynorphins; Dyskinesias; Enkephalins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger	2006